Zyto Group is a holding created from the acquisition of three companies: Zytomed Systems GmbH, ZytoVision GmbH and 42 Life Sciences GmbH & Co KG. Headquartered in Berlin and Northern Germany, Zyto Group offers consumables for Immunohistochemistry (IHC) and In-Situ Hybridization (ISH). Zyto Group is a niche manufacturer and supplier of specialty antibodies and probes that complement the testing capabilities of the most commonly used instruments in the market. The group directly sells to pathology labs in Germany and through distributors internationally.